Extracellular vesicle-mediated restraint of hepatic CD74–NF-κB repairs diabetic neuropathy
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Together, these data define a liver-to-nerve causal axis and support EV-mediated restraint of hepatic CD74–NF-κB signaling as a cross-organ strategy for DPN repair.
Limitation the authors admit
Systemically administered EVs predominantly accumulated in the liver and improved peripheral nerve structure and function, with benefits supported by glycemia-controlled or glycemia-adjusted analyses rather than being fully explained by systemic glycemic changes.
Appeared: Sunday, November 1. Science Advances. Peer-reviewed journal.